RNA, U6 small nuclear 853, pseudogene (RNU6-853P)

RNU6-853P (RNA, U6 small nuclear 853, pseudogene) is a human pseudogene related to the U6 small nuclear RNA (snRNA), which is a critical component of the spliceosome involved in the catalysis of pre-mRNA splicing[1][3]. Unlike functional U6 snRNA, RNU6-853P is classified as a pseudogene and does not encode a functional product. Pseudogenes are generally considered non-functional remnants of genes, although in some contexts, pseudogenes can exert regulatory roles through their RNA transcripts (e.g., acting as endogenous RNAs or competing for microRNA binding), but there is no specific evidence of such activity for RNU6-853P[2][7]. The pseudogene status means RNU6-853P is not involved directly in splicing or gene regulation, and it is not a therapeutic target or disease biomarker. No structural, functional, or interactome data are available for RNU6-853P specifically in the context of receptor, enzyme, or druggability[1]. Key Points: RNU6-853P is not a therapeutically actionable target or functional protein/receptor. It should not be classified as a receptor, enzyme, transporter, or similar druggable entity. Most information refers to the canonical U6 snRNA, not the pseudogene; pseudogenes like RNU6-853P may sometimes be co-opted for regulatory roles, but such roles must be empirically validated, and there is no evidence for this for RNU6-853P[2][7]. Scientific Context: Pseudogenes are genomic sequences similar to known genes but typically contain disabling mutations, preventing expression of a functional product. U6 snRNA pseudogenes reflect sequence similarity to the spliceosomal U6 snRNA but lack catalytic activity and are not involved in spliceosome function[3][7].

Other names

RNU6-853PRNA, U6 small nuclear 853, pseudogene